BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 12197572)

  • 1. Establishing a model of seasonal allergic rhinitis and demonstrating dose-response to a topical glucocorticosteroid.
    Ahlström-Emanuelsson C; Persson CG; Svensson C; Andersson M; Hosszu Z; Akerlund A; Greiff L
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):159-65. PubMed ID: 12197572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis.
    Ahlström-Emanuelsson C; Andersson M; Persson C; Schrewelius C; Greiff L
    Clin Exp Allergy; 2004 May; 34(5):731-5. PubMed ID: 15144464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-dependent effects of budesonide aqueous nasal spray on symptoms in a daily nasal allergen challenge model.
    Andersson M; Svensson C; Persson C; Akerlund A; Greiff L
    Ann Allergy Asthma Immunol; 2000 Oct; 85(4):279-83. PubMed ID: 11061470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
    Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis.
    Lange B; Lukat KF; Rettig K; Holtappels G; Bachert C
    Ann Allergy Asthma Immunol; 2005 Sep; 95(3):272-82. PubMed ID: 16200819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
    Korsgren M; Andersson M; Borgå O; Larsson L; Aldén-Raboisson M; Malmqvist U; Greiff L
    Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis.
    Bronsky EA; Aaronson DW; Berkowitz RB; Chervinsky P; Graft D; Kaiser HB; Moss B; Nathan RA; Pearlman DS; Ratner PH; Adelglass JM; Southern DL; van Bavel J; Hampel F; Stricker WE; Fourré JA; Cuss FM; Nolop KB
    Ann Allergy Asthma Immunol; 1997 Jul; 79(1):51-6. PubMed ID: 9236500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis.
    Anolik R;
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):264-71. PubMed ID: 18426147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effectiveness of mometasone furoate nasal spray in seasonal allergic rhinitis. First experiences in practice after the introduction of the drug in Hungary].
    Farkas H; Pintér J; Kalabay L; Jakab L; Visy B; Fekete B
    Orv Hetil; 2002 Aug; 143(33):1929-33. PubMed ID: 12244656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal spray.
    Gawchik S; Goldstein S; Prenner B; John A
    Ann Allergy Asthma Immunol; 2003 Apr; 90(4):416-21. PubMed ID: 12722964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge.
    Ciprandi G; Tosca MA; Passalacqua G; Canonica GW
    Ann Allergy Asthma Immunol; 2001 Apr; 86(4):433-8. PubMed ID: 11345288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate.
    Bielory L
    Ann Allergy Asthma Immunol; 2008 Mar; 100(3):272-9. PubMed ID: 18434976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topical formoterol alone and in combination with budesonide in a pollen season model of allergic rhinitis.
    Ahlström Emanuelsson C; Andersson M; Persson CG; Thorsson L; Greiff L
    Respir Med; 2007 Jun; 101(6):1106-12. PubMed ID: 17215115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intranasal mometasone furoate on itchy ear and palate in patients with seasonal allergic rhinitis.
    Bernstein DI; Teper A; Gopalan G; Gates D
    Ann Allergy Asthma Immunol; 2012 May; 108(5):359-62. PubMed ID: 22541408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. The 194-079 Study Group.
    Mandl M; Nolop K; Lutsky BN
    Ann Allergy Asthma Immunol; 1997 Sep; 79(3):237-45. PubMed ID: 9305231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis.
    Frieri M; Therattil J; Chavarria V; Cosachov J; Kumar NS; Wang SF; Sansone G; Etzel J; Dellevecchia D; Zitt M; Mesarina-Wicki B; Nolop KB
    Ann Allergy Asthma Immunol; 1998 Nov; 81(5):431-7. PubMed ID: 9860036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep.
    Meltzer EO; Munafo DA; Chung W; Gopalan G; Varghese ST
    Ann Allergy Asthma Immunol; 2010 Jul; 105(1):65-74. PubMed ID: 20642206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials.
    Penagos M; Compalati E; Tarantini F; Baena-Cagnani CE; Passalacqua G; Canonica GW
    Allergy; 2008 Oct; 63(10):1280-91. PubMed ID: 18721246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal mometasone furoate alleviates the ocular symptoms associated with seasonal allergic rhinitis: results of a post hoc analysis.
    Anolik R; Nathan RA; Schenkel E; Danzig MR; Gates D; Varghese S
    Int Arch Allergy Immunol; 2008; 147(4):323-30. PubMed ID: 18622139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide.
    Agertoft L; Pedersen S
    J Allergy Clin Immunol; 1999 Nov; 104(5):948-52. PubMed ID: 10550737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.